1147014-44-5 Usage
General Description
4-ethynyl-7H-Pyrrolo[2,3-d]pyrimidine is a chemical compound with the molecular formula C8H5N3. It is a heterocyclic compound containing a pyrimidine ring fused with a pyrrole ring, and has an ethynyl group attached to the pyrimidine ring. 7H-Pyrrolo[2,3-d]pyrimidine, 4-ethynyl- has potential applications in medicinal chemistry and drug development, as it can act as a precursor or intermediate in the synthesis of various pharmaceutical compounds. It is also used in organic synthesis and chemical research as a building block for the creation of more complex molecules. The compound has been the subject of research and experimentation due to its interesting chemical and pharmacological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1147014-44-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,7,0,1 and 4 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1147014-44:
(9*1)+(8*1)+(7*4)+(6*7)+(5*0)+(4*1)+(3*4)+(2*4)+(1*4)=115
115 % 10 = 5
So 1147014-44-5 is a valid CAS Registry Number.
1147014-44-5Relevant articles and documents
Solution-phase parallel synthesis of ruxolitinib-derived Janus kinase inhibitors via copper-catalyzed azide-alkyne cycloaddition
Gehringer, Matthias,Forster, Michael,Laufer, Stefan A.
supporting information, p. 5 - 10 (2015/01/30)
A solution-phase parallel synthesis of triazole-derived ruxolitinib analogues was developed in the current study. The method employs copper-catalyzed azide-alkyne cycloaddition to build up the central triazole template. Product isolation by precipitation
